Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-224

Decitabine for Injection is a cytotoxic agent that is available in a single-dose sterile vial containing 50mg per vial. The vial should be stored between 20°-25°C (68°-77°F), and excursions between 15°C-30°C (59°F-86°F) are allowed. To reconstitute, use 10mL of Sterile Water for Injection, USP. After reconstitution, unless used within 15 minutes, the diluted solution should be prepared using cold infusion fluids, stored at 2°C-6°C (35°F-43°F), and should be used for up to a maximum of 4 hours during self-administration. For complete indications, dosage, administration, and precautions, refer to the package insert. Unused portions should be discarded.*

Decitabine is a cytotoxic agent that is available in a single-dose sterile vial. Each vial contains 50 mg decitabine, 68 mg monobasic potassium phosphate, and 11.6 mg sodium hydrosice. It is meant for intravenous infusion only, and details of reconstitution, dosage, and precautions are given in the package insert and/or carton. The vial should be stored between 20°C and 25°C, with permissible excursions between 15°C and 30°C. Unused portions should be discarded. The drug is manufactured by Infas Pharmaceuticals Limited, Ahmedabad, India and marketed by Accord Healthcare, Inc, Durham, USA. The license number for this product is not available.*